Navigation Links
Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
Date:8/7/2008

ection technology aims to assist radiologists in the detection of colorectal neoplasia (polyps) by automatically highlighting suspicious areas on CT colonography scan images. The software may also help radiologists detect potentially malignant tumours at an early stage when treatment is most likely to be successful.

About MGT Capital Investments, Inc.

MGT Capital Investments, Inc. is a technology holding company that focuses on investments in the global healthcare information technology market. The Company has two subsidiaries, Medicsight PLC and Medicexchange PLC.

Medicsight PLC (AIM: MDST) is a UK-headquartered, research driven, leading developer of computer-aided detection (CAD) and image analysis software for the medical imaging market. The CAD software automatically highlights suspicious areas on computerised tomography (CT) scans of the colon and lung, helping radiologists to identify, measure and analyse potential disease and early indicators of disease. Medicsight's CAD software has been validated using one of the world's largest and most population diverse databases of verified patient CT scan data. Medicsight's ColonCAD(TM) and LungCAD(TM) software products are seamlessly integrated with the advanced 3D visualisation workstations of several industry-leading imaging equipment partners.

Medicexchange PLC provides medical imaging professionals with a global web portal containing an online sales, jobs and information channel for diagnostic, treatment and surgery planning solutions. This combined with a variety of relevant clinical papers, training materials and content gives these professionals access to information and products that they otherwise would have difficulty accessing.

Additional information can be found at http://www.mgtci.com.

All forward-looking statements are made pursuant to the 'safe harbor' provisions of the Private Securities Litigation Reform Act of
'/>"/>

SOURCE MGT Capital Investments, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Medicsight to Present at Piper Jaffray Annual Europe Conference
2. Medicsight Announces Chinese State Food and Drug Administration Approval for MedicRead Colon Workstation
3. Medicsight Announces New Marketing Partnership with INFINITT
4. Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer
5. ImQuest Receives $6.4 M Five Year Award from NIH to Develop Long-Lasting Combination Topical Microbicides To Prevent HIV Transmission
6. Kiwa Bio-Tech Receives Nationally Recognized Organic Products Certification
7. Alfacell Receives NASDAQ Delisting Letter
8. Silence Therapeutics Receives Allowance from United States Patent and Trademark Office for its Core RNAi Patent
9. Workforce Alliance Receives U.S. Labor Departments Excellence Award
10. Osteotechs Plexur M(TM) Biocomposite Receives FDA Clearance in Spine
11. OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... The report “Fragrance Ingredients Market by Type (Essential ... and Soaps & Detergents) & by Geography - Global ... the Fragrance Ingredients Market with analyses and projection of ... market has been segmented on the basis of major ... and Rest of the World (ROW); and their value ...
(Date:10/30/2014)... 2014 Deep Research Report on ... professional and in-depth research report on the China ... information, including its definition, classification, application, and industry ... research covers the international market analysis, including China’s ... covering macroeconomic environment & economic situation analysis. The ...
(Date:10/30/2014)... James Sherley says he has been working ... cell technology since his days as a principal investigator at ... late 1990’s. Sherley founded the ASCTC as a new ... the intellectual property developed in Sherley’s research over the years ... of Technology (MIT), and more recently as a senior scientist ...
(Date:10/30/2014)... Al Khaimah, UAE (PRWEB) October 30, 2014 ... appointment of Dr. James A. Manganello, Chairman of the Board, ... of The Bahamas. The appointment was made by the ... Bahamas on September 24th, 2014. , More than ... Therapy and Research Bill , Prime Minister Perry Christie said ...
Breaking Biology Technology:Fragrance Ingredients Market worth $17,104.21 Million by 2019 - New Report by MarketsandMarkets 2Fragrance Ingredients Market worth $17,104.21 Million by 2019 - New Report by MarketsandMarkets 3Fragrance Ingredients Market worth $17,104.21 Million by 2019 - New Report by MarketsandMarkets 4Fragrance Ingredients Market worth $17,104.21 Million by 2019 - New Report by MarketsandMarkets 5Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 2Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 3Boston’s Adult Stem Cell Technology Center, LLC Introduces A New Technology for Monitoring Previously Elusive Adult Stem Cells 4Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 2Grace Century’s Stem Cell Biobank Project Announces Chairman’s Appointment to National Stem Cell Ethics Committee of The Bahamas 3
... serious, hereditary ... bleeding disorder, found in region, KING OF PRUSSIA, Pa., ... Health and Medical Education (MOHME) has,granted rights to the company ... immediately. Haemate P is indicated for,the treatment of von Willebrand ...
... Special Protocol Assessment for Reviroc, AMSTERDAM, December ... successfully completed an End of Phase II meeting ... (FDA). Reviroc is under,development for elimination of cancer ... for end-stage blood cancer patients. The FDA,agreed that ...
... Avastin offers patients the chance to live twice as long without ... ... 19 Avastin (bevacizumab),Roche,s innovative anti-cancer drug, was approved today in ... (RCC) in,combination with interferon (IFN), the current standard of care*. Kidney,cancer, ...
Cached Biology Technology:CSL Behring Expands Into Middle East Market with Haemate(R) P 2CSL Behring Expands Into Middle East Market with Haemate(R) P 3Kiadis Pharma Reports Successful End of Phase II Meeting With FDA for Reviroc 2Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer 2Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer 3
(Date:10/31/2014)... creating green space in cities is good for attracting species, ... built environments, a University of Iowa study has found. , ... area in Iowa, and recorded the abundance of two insects ... plenty of the trees, black cherry and black walnut, they ... case fruit flies that feed on the walnuts and black ...
(Date:10/31/2014)... NEW YORK , Oct. 30, 2014 /PRNewswire-USNewswire/ ... lab, is pleased to announce its inaugural HITLAB ... at Columbia University,s Low Library. HITLAB will partner ... & Saatchi Wellness, Blueprint Health, ProtoHack, Columbia Business ... , and Columbia Industrial Engineering and Operations ...
(Date:10/30/2014)... 2014—Oligonucleotide-based therapeutics present unique challenges when it comes ... developmental harm. New consensus guidelines for toxicity testing ... biological characteristics of these novel biopharmaceuticals are presented ... journal from Mary Ann Liebert, Inc. publishers ... Nucleic Acid Therapeutics website until November ...
Breaking Biology News(10 mins):Green spaces don't ensure biodiversity in urban areas 2HITLAB Announces Inaugural HITLAB Innovators Summit 2HITLAB Announces Inaugural HITLAB Innovators Summit 3New guidelines for reproductive & developmental toxicity testing of oligonucleotide drugs 2
... from the Technische Universitaet Muenchen are to receive ... ten million euros to support pioneering research projects: ... impact of extreme weather events on ecosystems. Prof. ... for enhanced data processing. Prof. Rdiger Westermann (2.3M) ...
... world,s coastal marine ecosystems are being overlooked, both in ... a rallying point for conservation. Writing in Aquatic ... Dr. Amanda Vincent argues that increased protections are needed ... world,s oceans, where the richest diversity of marine habitats ...
... important biological processes. However, it is less efficient in ... use a slightly different mechanism and are thus more ... (MPIB) in Martinsried near Munich, Germany, have now identified ... red algae. "We could elucidate its structure and its ...
Cached Biology News:10 million euros for pioneering research projects at TU Muenchen 210 million euros for pioneering research projects at TU Muenchen 310 million euros for pioneering research projects at TU Muenchen 410 million euros for pioneering research projects at TU Muenchen 510 million euros for pioneering research projects at TU Muenchen 610 million euros for pioneering research projects at TU Muenchen 7Conservationists call for increased focus on coastal ecosystems 2Shoe strings and egg openers 2
... Yellow crystalline solid. PROTECT FROM LIGHT. Useful in ... required. Purity: ≥98% by TLC. Soluble in ... preparation of a 10 mM stock in DMSO is ... to H 2 O with rapid mixing (e.g. 10 ...
Monoclonal antibodies conjugated with rhodamine...
... Mouse monoclonal [RET-P1] to Rhodopsin Rhodopsin ... pigment in mammals, birds, amphibians, and reptiles. ... photoreceptor cells in the retina. ... retina. Specificity: This antibody ...
... 2HCl White to off-white ... inhibitor. Inhibits translation by causing premature ... DNA fragmentation in thymocytes and in ... ≥98% by TLC. Soluble in ...
Biology Products: